The results of the study have shown that the regimen is safe and effective: All patients had 3 cycles of neoadjuvant chemotherapy for a compliance rate of 100%, while concurrent chemotherapy had 87, 3% compliance rate for 4 cycles or more, 100% compliance rate for radiotherapy treatment.